Skip to main content

Table 3 Excluded studies from meta-analysis due to confounding factors

From: Weekly Training Frequency Effects on Strength Gain: A Meta-Analysis

Study

N

Age, years (mean ± SD)

Duration

Testing modality

Sets (reps)

Days trained per week

Frequency per week

Pre- vs. post-intervention kg,

mean ± SD

Pre- vs. post-intervention

strength difference

kg (% change)

p value (pre vs. post)

ES

Gomes et al. [20]

12

11

25.5 (± 1.25)

27.1 (± 1.85)

8 weeks

Sq

5–10 (8–12)

1

5

LF

HF

132.9 ± 28.0 vs. 140.9 ± 25.5

123.3 ± 17.5 vs. 135.3 ± 22.2

8 (6.02)

12 (9.73)

0.47

0.17

0.30

0.60

Gomes et al. [20]

12

11

25.5 (± 1.25)

27.1 (± 1.85)

8 weeks

BP

5–10 (8–12)

1

5

LF

HF

103.5 ± 15.4 vs. 109.1 ± 18.5

100.6 ± 14.5 vs. 110.3 ± 12.1

5.6 (5.41)

9.7 (9.64)

0.43

0.10

0.33

0.73

Serra et al. [21]

26

32

16

35.3 (± 1.75)

34 (± 2)

34.85 (± 0.85)

3 months

WG PullD

3 (10–20)

2

3

4

MF

HF

HF

42.6 ± 20.7 vs. 48.5 ± 20.7

44.4 ± 13.9 vs. 51.3 ± 13.9

40.6 ± 20.3 vs. 48.6 ± 21.8

5.9 (13.8)

6.9 (13.5)

8 (16.5)

≤ 0.001 a

≤ 0.001a

≤ 0.001a

0.29

0.50

0.38

Serra et al. [21]

26

32

16

35.3 (± 1.75)

34 (± 2)

34.85 (± 0.85)

3 months

CP

3 (10–20)

2

3

4

MF

HFe

HF

41.2 ± 25.6 vs. 49.9 ± 30.2

46.6 ± 20.8 vs. 59.7 ± 25.1

42.1 ± 27.9 vs. 55.6 ± 36.2

8.7 (21.1)

13.1 (28.1)

13.5 (32.1)

≤ 0.001a

≤ 0.001a

≤ 0.00a

0.31

0.57

0.42

Serra et al. [21]

26

32

16

35.3 (± 1.75)

34 (± 2)

34.85 (± 0.85)

3 months

LP

3 (10–20)

2

3

4

MF

HFe

HF

108.9 ± 49.1 vs. 128.9 ± 54.5

120.2 ± 48.0 vs. 149.0 ± 57.7

128.8 ± 55.4 vs. 168.1 ± 89.0

20 (18.4)

28.8 (24.0)

39.3 (30.5)

≤ 0.001a

≤ 0.001a

≤ 0.001a

0.39

0.54

0.53

Yue et al. [23]

9

9

28 (± 7.9)

21 (± 3.2)

6 weeks

Sq

4 (8–12)

2 (8–12)

2

4

MF

HF

103 ± 27 vs. 115 ± 34

90 ± 9 vs. 103 ± 13

12 (11.7)

13 (14.4)

≤ 0.001a

≤ 0.001a

0.39

1.16

Yue et al. [23]

9

9

28 (± 7.9)

21 (± 3.2)

6 weeks

BP

4 (8–12)

2 (8–12)

2

4

MF

HF

77 ± 27 vs. 88 ± 30

70 ± 17 vs. 81 ± 15

11 (14.3)

11 (15.7)

≤ 0.001a

≤ 0.001a

0.39

0.69

Carpenter et al. [34]

10

12

12

7

31(± 31)

20 weeks

LumExt

1 (8–12)

0.5

2

3

4

LF

MF

HF

HF

73.6 ± 24.7 vs. 98.2 ± 32.8

58.9 ± 18.0 vs. 86.2 ± 28.0

69.9 ± 27.5 vs. 105.9 ± 40.8

78.2 ± 21.4 vs. 115.8 ± 31.3

24.6 (33.4)

27.3 (46.3)

36 (51.5)

37.6 (48.1)

≤ 0.05b

≤ 0.05b

≤ 0.05b

≤ 0.05b

0.85

1.16

1.03

1.40

Pollock et al. [35]

14

19

26 (± 9)

30 (± 9)

12 weeks

CervExt

1 (8–12)

1

2

LF

MF

28.3 ± 6.7 vs. 38.2 ± 7.8

27.4 ± 8.5 vs. 38.2 ± 10.9

9.9 (35.0)

10.8 (40.9)

0.001a

0.002b

1.36

1.10

Taaffe et al. [40]

11

12

11

68.5 (± 3.6)

69.4 (± 3.0)

71.0 (± 4.1)

24 weeks

LPull

3 (8)

1

2

3

LF

MF

HF

36.0 ± 14.2 vs. 45.3 ± 4.31

35.8 ± 9.7 vs. 47.0 ± 4.20

33.6 ± 10.9 vs. 48.9 ± 4.31

9.3 (25.83)

11.2 (31.28)

15.3 (45.54)

≤ 0.001a

≤ 0.001a

≤ 0.001a

0.89

1.50

1.85

Taaffe et al. [40]

11

12

11

68.5 (± 3.6)

69.4 (± 3.0)

71.0 (± 4.1)

24 weeks

BC

3 (8)

1

2

3

LF

MF

HF

16.5 ± 7.1 vs. 21.9 ± 2.99

17.0 ± 4.3 vs. 24.4 ± 2.77

16.7 ± 6.2 vs. 23.2 ± 2.99

5.4 (32.73)

7.4 (43.53)

6.5 (38.92)

≤ 0.001a

≤ 0.001a

≤ 0.001a

0.99

2.05

1.34

Taaffe et al. [40]

11

12

11

68.5 (± 3.6)

69.4 (± 3.0)

71.0 (± 4.1)

24 weeks

BExt

3 (8)

1

2

3

LF

MF

HF

62.3 ± 24.5 vs. 83.1 ± 9.17

63.4 ± 11.3 vs. 84.2 ± 9.70

65.0 ± 26.5 vs. 84.4 ± 9.29

20.8 (33.39)

20.8 (32.81)

19.4 (29.85)

≤ 0.001a

≤ 0.001a

≤ 0.001a

1.12

1.98

0.98

Taaffe et al. [40]

11

12

11

68.5 (± 3.6)

69.4 (± 3.0)

71.0 (± 4.1)

24 weeks

LP

3 (8)

1

2

3

LF

MF

HF

109.5 ± 29.8 vs. 135.2 ± 12.27

113.3 ± 19.3 vs. 142.8 ± 12.47

110.5 ± 29.5 vs. 145.1 ± 3.7

25.7 (23.47)

29.5 (26.04)

34.6 (31.31)

≤ 0.001a

≤ 0.001a

≤ 0.001a

1.13

1.82

1.65

Taaffe et al. [40]

11

12

11

68.5 (± 3.6)

69.4 (± 3.0)

71.0 (± 4.1)

24 weeks

KExt

3 (8)

1

2

3

LF

MF

HF

39.3 ± 15.4 vs. 67.1 ± 10.95

43.2 ± 8.6 vs. 72.6 ± 10.74

42.4 ± 12.4 vs. 62.6 ± 10.61

27.8 (70.74)

29.4 (68.06)

20.2 (47.64)

≤ 0.001a

≤ 0.001a

≤ 0.001a

2.08

3.02

1.75

Taaffe et al. [40]

10

12

11

68.5 (± 3.6)

69.4 (± 3.0)

71.0 (± 4.1)

24 weeks

KFlex

3 (8)

1

2

3

LF

MF

HF

16.3 ± 7.5 vs. 28.4 ± 4.43

19.6 ± 6.8 vs. 30.4 ± 4.50

20.0 ± 9.4 vs. 28.5 ± 4.64

12.1 (74.23)

10.8 (55.10)

8.5 (42.50)

≤ 0.001a

≤ 0.001a

≤ 0.001a

1.96

1.87

1.15

Farinatti et al. [41]

10

11

10

72 (± 5.0)

66 (± 7.0)

68 (± 4.0)

16 weeks

DumBP

1 (8–12)

1

2

3

LF

MF

HF

8.2 ± 1.8 vs. 13.0 ± 2.0

9.6 ± 2.2 vs. 14.4 ± 5.2

10.4 ± 0.9 vs. 15.6 ± 1.7

4.8 (58.54)

4.8 (50.0)

5.2 (50.0)

≤ 0.01a

≤ 0.01a

≤ 0.01a

2.52

1.20

3.82

Farinatti et al. [41]

10

11

10

72 (± 5.0)

66 (± 7.0)

68 (± 4.0)

16 weeks

DCur

1 (8–12)

1

2

3

LF

MF

HF

7.8 ± 1.5 vs. 12.2 ± 2.3

8.4 ± 1.7 vs. 13.6 ± 2.6

9.2 ± 1.8 vs. 15.6 ± 0.9

4.4 (56.41)

5.2 (61.90)

6.4 (69.57)

≤ 0.01a

≤ 0.01a

≤ 0.01a

2.27

2.37

4.50

Farinatti et al. [41]

10

11

10

72 (± 5.0)

66 (± 7.0)

68 (± 4.0)

16 weeks

KExt

1 (8–12)

1

2

3

LF

MF

HF

18.0 ± 3.7 vs. 25.6 ± 3.2

19.2 ± 4.6 ± 29.6 ± 7.4

19.8 ± 4.9 vs. 32.0 ± 6.8

7.6 (42.22)

10.4 (54.17)

12.2 (61.62)

≤ 0.01a

≤ 0.01a

≤ 0.01a

2.20

1.69

2.06

Farinatti et al. [42]

10

11

10

72 (± 5.0)

66 (± 7.0)

68 (± 4.0)

16 weeks

StCR

1 (8–12)

1

2

3

LF

MF

HF

12.0 ± 2.0 vs. 16.8 ± 1.9

12.2 ± 3.0 vs. 17.0 ± 3.7

11.8 ± 0.5 vs. 16.8 ± 1.5

4.8 (40.0)

4.8 (39.34)

5.0 (42.37)

≤ 0.01a

≤ 0.01a

≤ 0.01a

2.46

1.43

4.47

Burt et al. [42]

10

11

Students

8 weeks.

LP

1 (6–10)

1

2

LF

MF

263.31 ± 37.23 vs. 362.65 ± 51.06

244.89 ± 45.80 vs. 391.53 ± 45.18

99.34 (99.34)

146.64 (59.9)

≤ 0.0001a

≤ 0.0001a

2.22

3.22

Serra et al. [67]

18

17

10

41.4 (± 9.9)

4 months

8 months

BP

3 (10–12)

2

3

4

MF

HF

HF

41.7 ± 16.4 vs. 57.4 ± 15.4

38.8 ± 16.3 vs. 59.5 ± 16.5

39.0 ± 16.1 vs. 62.8 ± 18.1

36.3 (37.6)

46.5 (53.4)

65.1 (61.0)

0.01a

0.001a

0.01a

0.99

1.26

1.39

Serra et al. [67]

18

17

10

41.4 (± 9.9)

4 months

8 months

LP

3 (10–12)

2

3

4

MF

HF

HF

83.3 ± 21.4 vs. 113.3 ± 26.6

88.2 ± 21.9 vs. 112.5 ± 18.5

80.0 ± 25.4 vs. 117.8 ± 30.5

30.4 (36.01)

32.4 (27.6)

45.4 (47.3)

0.001a

≤ 0.001a

0.01a

1.24

1.20

1.35

Serra et al. [67]

18

17

10

41.4 (± 9.9)

4 months

8 months

LPull

3 (10–12)

2

3

4

MF

HF

HF

50.1 ± 12.0 vs. 67.4 ± 12.0

52.2 ± 12.8 vs. 69.7 ± 17.0

54.5 ± 16.2 vs. 77.5 ± 18.1

29.4 (34.5)

32.0 (33.5)

46.0 (42.2)

0.0001a

0.002a

0.01a

1.44

1.16

1.34

Benton et al. [36]

11

10

47.6 (± 1.2)

8 weeks

CP

3–6 (8–12)

3

4

HF

HF

37.4 ± 2.5 vs. 50.0 ± 3.5

44.5 ± 3.0 vs. 59.7 ± 4.1

12.6 (34.0)

15.2 (34.2)

≤ 0.001a

≤ 0.001a

1.25

1.34

Benton et al. [36]

11

10

47.6 (± 1.2)

8 weeks

LP

3–6 (8–12)

3

4

HF

HF

105.1 ± 9.8 vs. 135.7 ± 16.7

119.7 ± 11.5 vs. 178.6 ± 19.6

30.6 (29.1)

58.9 (49.2)

≤ 0.001a

≤ 0.001a

0.67

1.16

Ribeiro et al. [37]

5

5

26.7 (± 2.7)

4 weeks

BP

4 (6–20)

4

6

HF

HF

104.4 ± 19.3 vs. 113.2 ± 23.0

105.6 ± 16.4 vs. 117.6 ± 16.3

8.8 (8.4)

12 (11.4)

0.53

0.28

0.41

0.73

Hoffman et al. [38]

12

15

23

11

19.7 ± (1.4)

20.1 ± (1.5)

20.1 ± (1.1)

19.7 ± (1.1)

10 weeks.

BP

1–5 (2–10)

3

4

5

6

HF

HF

HF

HF

107.2 ± 11.6 vs. 109.1 ± 28.7

127.7 ± 13.9 vs. 132.2 ± 14.5

131.1 ± 20.1 vs. 135.3 ± 19.0

143.9 ± 12.0 vs. 149.7 ± 17.3

1.9 (1.8)

4.5 (3.5)

4.2 (3.2)

5.8 (4.0)

0.83

0.39

0.47

0.37

0.09

0.32

0.21

0.39

Hoffman et al. [38]

12

15

23

11

19.7 ± (1.4)

20.1 ± (1.5)

20.1 ± (1.1)

19.7 ± (1.1)

10 weeks.

Sq

1–5 (2–10)

3

4

5

6

HF

HF

HF

HF

140.1 ± 18.6 vs. 147.4 ± 38.9

173.6 ± 36.2 vs. 186.3 ± 31.9

170.6 ± 19.4 vs. 183.4 ± 22.1

191.6 ± 34.9 vs. 204.1 ± 39.5

7.3 (5.2)

12.7 (7.3)

12.8 (7.5)

12.5 (6.5)

0.56

0.32

0.04a

0.44

0.24

0.37

0.62

0.34

Padilha et al. [43]

13

14

68.9 (± 5.0)

66.7 (± 13.9)

12 weeks

CP

1 (10–15)

2

3

MF

HF

35.7 ± 6.6 vs. 42.2 ± 8.0

37.1 ± 3.8 vs. 47.3 ± 4.6

6.5 (18.2)

10.2 (27.5)

≤ 0.05b

≤ 0.05b

0.89

2.42

Padilha et al. [43]

13

14

68.9 (± 5.0)

12 weeks

LE

1 (10–15)

2

3

MF

HF

41.3 ± 9.3 vs. 48.9 ± 9.1

46.1 ± 10.5 vs. 53.8 ± 12.5

7.6 (18.4)

7.7 (16.7)

≤ 0.05b

≤ 0.05b

0.83

0.67

Padilha et al. [43]

13

14

66.7 (± 13.9)

12 weeks

BC

1 (10–15)

2

3

MF

HF

17.0 ± 3.3 vs. 23.4 ± 3.8

17.7 ± 2.5 vs. 24.2 ± 3.6

6.4 (37.6)

6.5 (26.9)

≤ 0.05b

≤ 0.05b

1.80

2.10

Hunter [39]

14

10

22.2 (± 2.2) c

7 weeks

BP

2–3 (7–10)

3

4

HF

HF

69.1 ± 22.08 vs. 77.3 ± 20.58

59.3 ± 25.93 vs. 69.20 ± 25.61

8.2 (11.9)

9.9 (16.7)

0.32

0.40

0.38

0.38

Hunter [39]

11

11

23.1 (± 0.9) d

7 weeks

BP

2–3 (7–10)

3

4

HF

HF

26.1 ± 5.97 vs. 31.3 ± 6.30

27.3 ± 7.30 vs. 36.40 ± 7.96

5.2 (19.9)

9.1 (33.3)

0.32

≤ 0.05b

0.85

1.19

  1. Abbreviations: N number of subjects, SD standard deviation, reps repetitions; per week number of days trained per week, ES effect size, Sq squat, LF low frequency (1 day per week), MF medium frequency (2 days per week), HF high frequency (≥ 3 day per week), BP bench press, WGPullD wide grip pulldown, CP chest press, LP leg press, LumExt lumbar extension, CervExt cervical extension, LPull lateral pulldown, BC bicep curl, BExt back extension, LP leg press, KExt knee extension, KFlex knee flexion, DumBP dumbbell bench press, DCurl dumbbell curl, StCR standing calf raise
  2. aSignificantly greater than prior to training (p ≤ 0.01)
  3. bSignificantly greater than prior to training (p ≤ 0.05)
  4. cMale-only subjects
  5. dFemale-only subjects